Egawa H, Ohdan H, Saito K. Current status of ABO-incompatible liver transplantation. Transplantation. 2023;107:313–25.

CAS  PubMed  Google Scholar 

Egawa H, Teramukai S, Haga H, Tanabe M, Mori A, Ikegami T, et al. Impact of rituximab desensitization on blood-type-incompatible adult living donor liver transplantation: a Japanese multicenter study. Am J Transpl. 2014;14:102–14.

CAS  Google Scholar 

Lee CF, Cheng CH, Wang YC, Soong RS, Wu TH, Chou HS, et al. Adult living donor liver transplantation across ABO-incompatibility. Medicine (Baltimore). 2015;94:e1796.

CAS  PubMed  Google Scholar 

Ikegami T, Yoshizumi T, Soejima Y, Uchiyama H, Shirabe K, Maehara Y. Feasible usage of ABO incompatible grafts in living donor liver transplantation. Hepatobiliary Surg Nutr. 2016;5:91–7.

PubMed  PubMed Central  Google Scholar 

Kusakabe J, Yagi S, Sasaki K, Uozumi R, Abe H, Okamura Y, et al. Is 0.6% reasonable as the minimum requirement of the graft-to-recipient weight ratio regardless of lobe selection in adult living-donor liver transplantation? Transplantation. 2021;105:2007.

CAS  PubMed  Google Scholar 

Gil E, Kim JM, Jeon K, Park H, Kang D, Cho J, et al. Recipient age and mortality after liver transplantation: a population-based cohort study. Transplantation. 2018;102:2025–32.

PubMed  PubMed Central  Google Scholar 

Yeow M, Pang NQ, Muthiah MD, Soon G, Yock-Young D, Bonney GK, et al. Impact of donor age on recipient morbidity and mortality after living donor liver transplantation. ANZ J Surg. 2022;92:1867–72.

PubMed  Google Scholar 

Haga H, Egawa H, Shirase T, Miyagawa A, Sakurai T, Minamiguchi S, et al. Periportal edema and necrosis as diagnostic histological features of early humoral rejection in ABO-incompatible liver transplantion. Liver Transpl. 2004;10:16–27.

PubMed  Google Scholar 

Haga H, Egawa H, Fujimoto Y, Ueda M, Miyagawa-Hayashino A, Sakurai T, et al. Acute humoral rejection and C4d immunostaining in ABO blood type-incompatible liver transplantation. Liver Transpl. 2006;12:457–64.

PubMed  Google Scholar 

Tobian AAR, Shirey RS, Montgomery RA, Cai W, Haas M, Ness PM, et al. ABO antibody titer and risk of antibody-mediated rejection in ABO-incompatible renal transplantation. Am J Transpl. 2010;10:1247–53.

CAS  Google Scholar 

Kim JM, Kwon CHD, Joh JW, Kang ES, Park JB, Lee JH, et al. ABO-incompatible living donor liver transplantation is suitable in patients without ABO-matched donor. J Hepatol. 2013;59:1215–22.

PubMed  Google Scholar 

Kwon JH, Song GW, Hwang S, Kim KH, Ahn CS, Moon DB, et al. Dual-graft adult living donor liver transplantation with ABO-incompatible graft: short-term and long-term outcomes. Am J Transpl. 2018;18:424–33.

CAS  Google Scholar 

Dar W, Agarwal A, Watkins C, Gebel HM, Bray RA, Kokko KE, et al. Donor-directed MHC class i antibody is preferentially cleared from sensitized recipients of combined liver/kidney transplants. Am J Transpl. 2011;11:841–7.

CAS  Google Scholar 

Cuadrado A, San Segundo D, López-Hoyos M, Crespo J, Fábrega E. Clinical significance of donor-specific human leukocyte antigen antibodies in liver transplantation. World J Gastroenterol. 2015;21:11016–26.

CAS  PubMed  PubMed Central  Google Scholar 

Raut V, Mori A, Kaido T, Ogura Y, Taku I, Nagai K, et al. Splenectomy does not offer immunological benefits in ABO-incompatible liver transplantation with a preoperative rituximab. Transplantation. 2012;93:99–105.

CAS  PubMed  Google Scholar 

Lee SD, Kim SH, Kong SY, Kim YK, Lee SA, Park SJ. ABO-incompatible living donor liver transplantation without graft local infusion and splenectomy. HPB. 2014;16:807–13.

PubMed  PubMed Central  Google Scholar 

Walsh RC, Everly JJ, Brailey P, Rike AH, Arend LJ, Mogilishetty G, et al. Proteasome inhibitor-based primary therapy for antibody-mediated renal allograft rejection. Transplantation. 2010;89:277–84.

CAS  PubMed  Google Scholar 

Tajima T, Hata K, Okajima H, Nishikori M, Yasuchika K, Kusakabe J, et al. Bortezomib against refractory antibody-mediated rejection after ABO-incompatible living-donor liver transplantation: dramatic effect in acute-phase? Transpl Direct. 2019;5:e491.

CAS  Google Scholar 

Takamura H, Nakanuma S, Hayashi H, Tajima H, Kakinoki K, Kitahara M, et al. Severe veno-occlusive disease/sinusoidal obstruction syndrome after deceased-donor and living-donor liver transplantation. Transpl Proc. 2014;46:3523–35.

CAS  Google Scholar 

Sanada Y, Sakuma Y, Onishi Y, Okada N, Hirata Y, Horiuchi T, et al. Prevalence and outcomes of patients with sinusoidal obstruction syndrome after liver transplantation: a ten year’s experience of a single center in Japan. Transpl Immunol. 2022;71:101557.

PubMed  Google Scholar 

Endo Y, Shinoda M, Maehara J, Hibi T, Hasegawa Y, Obara H, et al. Early-onset hepatic veno-occlusive disease after liver transplantation: an institutional experience and analysis of a literature-based cohort. Surg Today. 2024;54:670–82.

CAS  PubMed  Google Scholar 

Baliellas C, Lladó L, Serrano T, Gonzalez-Vilatarsana E, Cachero A, Lopez-Dominguez J, et al. Sinusoidal obstruction syndrome as a manifestation of acute antibody-mediated rejection after liver transplantation. Am J Transpl. 2021;21:3775–9.

Google Scholar 

Yamada N, Urahashi T, Ihara Y, Sanada Y, Wakiya T, Okada N, et al. Veno-occlusive disease/sinusoidal obstruction syndrome associated with potential antibody-mediated rejection after pediatric living donor liver transplantation: a case report. Transpl Proc. 2012;44:810–3.

CAS  Google Scholar 

Lee TB, Yang K, Ko HJ, Shim JR, Choi BH, Lee JH, et al. Successful defibrotide treatment of a patient with veno-occlusive disease after living-donor liver transplantation: a case report. Medicine (Baltimore). 2021;100:26463.

Google Scholar